Maxigen Biotech Inc. (TPE:1783)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
42.00
+0.50 (1.20%)
Mar 10, 2026, 1:35 PM CST

Maxigen Biotech Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
731.12639.05431.08790.95513.31209.76
Upgrade
Short-Term Investments
---8.8213.84-
Upgrade
Cash & Short-Term Investments
731.12639.05431.08799.76527.15209.76
Upgrade
Cash Growth
34.46%48.24%-46.10%51.72%151.31%-50.03%
Upgrade
Accounts Receivable
122.37103.9188.3198.86109.9594.91
Upgrade
Other Receivables
0.66-8.751.424.767.32
Upgrade
Receivables
123.04103.9197.06100.27114.71102.23
Upgrade
Inventory
81.2975.7685.3275.4180.6388.02
Upgrade
Prepaid Expenses
12.119.824.5215.4147.7818.62
Upgrade
Other Current Assets
2.591.791.582.3913.2913.43
Upgrade
Total Current Assets
950.14830.33619.56993.25783.55432.06
Upgrade
Property, Plant & Equipment
452.42430.36424.18434.62465.45481.52
Upgrade
Long-Term Investments
297.39311.31432.8---
Upgrade
Other Intangible Assets
0.750.130.491.161.831.67
Upgrade
Long-Term Deferred Tax Assets
1.82.555.833.190.381.07
Upgrade
Other Long-Term Assets
5.057.8110.1315.513.9740.15
Upgrade
Total Assets
1,7081,5821,4931,4481,265956.47
Upgrade
Accounts Payable
79.0949.9817.1735.9440.1533
Upgrade
Accrued Expenses
71.8872.0764.6355.3540.3530.21
Upgrade
Current Portion of Leases
----2.362.49
Upgrade
Current Income Taxes Payable
12.5525.5224.4727.179.288.69
Upgrade
Current Unearned Revenue
18.5622.931.344.2511.133.76
Upgrade
Other Current Liabilities
44.4735.3723.7828.7912.88.42
Upgrade
Total Current Liabilities
226.55205.87131.37151.5116.0786.58
Upgrade
Long-Term Leases
----7.289.64
Upgrade
Long-Term Deferred Tax Liabilities
0.490.930.490.55--
Upgrade
Other Long-Term Liabilities
6.970.560.020.020.120.02
Upgrade
Total Liabilities
234.01207.36131.88152.07123.4796.24
Upgrade
Common Stock
896.8891.63889.34846.99769.99694.65
Upgrade
Additional Paid-In Capital
329.03326.93296.1281.9264.3989.18
Upgrade
Retained Earnings
450.83344.12244.46169.8110.379.38
Upgrade
Comprehensive Income & Other
-203.11-187.56-68.79-3.04-2.96-2.99
Upgrade
Total Common Equity
1,4741,3751,3611,2961,142860.23
Upgrade
Shareholders' Equity
1,4741,3751,3611,2961,142860.23
Upgrade
Total Liabilities & Equity
1,7081,5821,4931,4481,265956.47
Upgrade
Total Debt
----9.6412.13
Upgrade
Net Cash (Debt)
731.12639.05431.08799.76517.51197.63
Upgrade
Net Cash Growth
34.46%48.24%-46.10%54.54%161.86%3.72%
Upgrade
Net Cash Per Share
8.117.124.828.956.122.45
Upgrade
Filing Date Shares Outstanding
89.6889.1688.9388.9388.9380.23
Upgrade
Total Common Shares Outstanding
89.6889.1688.9388.9388.9380.23
Upgrade
Working Capital
723.59624.47488.19841.75667.49345.47
Upgrade
Book Value Per Share
16.4315.4215.3014.5712.8410.72
Upgrade
Tangible Book Value
1,4731,3751,3611,2941,140858.55
Upgrade
Tangible Book Value Per Share
16.4215.4215.3014.5612.8210.70
Upgrade
Land
133.23133.23133.23133.23133.23133.23
Upgrade
Buildings
312.5310.48307.74303.11302.48301.8
Upgrade
Machinery
206.68181.24160.52149.88162141.51
Upgrade
Construction In Progress
37.3520.0817.6721.618.7926.03
Upgrade
Leasehold Improvements
13.4313.4318.9118.9123.721.86
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.